Go Deep
Microbot Medical Inc.
Microbot Medical Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,898 | -4.1 | 0.90 | 0.01 | 94.14 |
| Oct 2026 | 21,985 | -4.0 | 0.86 | 0.01 | 90.21 |
| Oct 2026 | 21,909 | -3.8 | 0.86 | 0.01 | 89.98 |
| Oct 2026 | 21,903 | -3.8 | 0.86 | 0.01 | 90.34 |
| Oct 2026 | 21,898 | -3.8 | 0.86 | 0.01 | 89.84 |
| Oct 2026 | 21,914 | -3.8 | 0.85 | 0.01 | 88.92 |
| Oct 2026 | 21,910 | -3.8 | 0.85 | 0.01 | 88.91 |
Microbot Medical Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | — | 105,000.0 | 0.0 | 0.0 |
| Net Profit | — | -3,671,000.0 | -3,464,000.0 | -3,577,000.0 |
| EPS | -0.1 | -0.1 | — | -0.1 |
Microbot Medical Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Net Profit | -13,142,000.0 | -11,443,000.0 | -10,740,000.0 | -13,168,000.0 | — |
| EPS | -0.3 | -0.7 | -1.1 | -1.8 | — |
Microbot Medical Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 81,544,000.0 | 6,031,000.0 | 8,327,000.0 | 9,537,000.0 | — |
| Total Liabilities | 3,990,000.0 | 2,501,000.0 | 3,826,000.0 | 2,248,000.0 | — |
| Total Equity | 77,554,000.0 | 3,530,000.0 | 4,501,000.0 | 7,289,000.0 | — |
Owes vs Owns
Microbot Medical Inc. owed $0.05 for every $1 it owned in Mar 2026, down from $0.24 in Dec 2022.
| Period | Mar 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.05× | 0.05× | 0.41× | 0.46× | 0.24× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Microbot Medical Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 96.4%Receivables 0.8%Inventory 0.7%Fixed assets (tangible) 1.1%Other assets 1.0%
How it's funded — Dec 2025
Long-term debt 0.7%Payables 0.6%Other liabilities 3.2%Shareholders' equity 95.1%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 78.6 | 5.5 | 6.4 | 8.2 |
| Receivables | 0.6 | 0.3 | 1.5 | 0.5 |
| Inventory | 0.6 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 0.9 | 0.2 | 0.4 | 0.7 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 0.8 | 0.0 | 0.0 | 0.1 |
| Liabilities & equity | ||||
| Short-term debt | 0.3 | 0.1 | 0.2 | 0.3 |
| Long-term debt | 0.6 | 0.0 | 0.0 | 0.2 |
| Payables | 0.5 | 0.2 | 0.4 | 0.1 |
| Other liabilities | 2.6 | 2.2 | 3.2 | 1.7 |
| Shareholders' equity | 77.6 | 3.5 | 4.5 | 7.3 |
| Net tangible assets | 77.6 | 3.5 | 4.5 | 7.3 |
Microbot Medical Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -13,046,000.0 | -8,827,000.0 | -8,533,000.0 | -11,549,000.0 | — |
| Investing Activities | -72,384,000.0 | 1,537,000.0 | 1,973,000.0 | -3,836,000.0 | — |
| Financing Activities | 86,240,000.0 | 7,936,000.0 | 6,558,000.0 | 4,324,000.0 | — |